INNOVIVA, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
INNOVIVA, INC. (INVA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 11.91 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- INNOVIVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 11.91M shares, a 630.86% increase year-over-year.
- INNOVIVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.09M shares, a 95.27% decline year-over-year.
- INNOVIVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 1.52M shares, a 93.16% decline year-over-year.
- INNOVIVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 1.63M shares, a 93.09% decline year-over-year.
- INNOVIVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.53M shares, a 86.93% decline from fiscal 2024.
- INNOVIVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 11.74M shares, a 510.29% increase from fiscal 2023.
- INNOVIVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.92M shares, a 106.88% increase from fiscal 2022.
- INNOVIVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 930.00K shares, a 5.01% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 11.91M shares 10-Q · filed 2026-08-05 | 1.39M shares 10-Q · filed 2026-08-05 | ||||||
| 2026-03-31 | 1.09M shares 10-Q · filed 2026-05-06 | |||||||
| 2025-12-31 | 1.53M shares 10-K · filed 2026-02-25 | |||||||
| 2025-09-30 | 1.52M shares 10-Q · filed 2025-11-05 | 1.48M shares 10-Q · filed 2025-11-05 | ||||||
| 2025-06-30 | 1.63M shares 10-Q · filed 2026-08-05 | 1.39M shares 10-Q · filed 2026-08-05 | ||||||
| 2025-03-31 | 23.08M shares 10-Q · filed 2026-05-06 | |||||||
| 2024-12-31 | 11.74M shares 10-K · filed 2026-02-25 | |||||||
| 2024-09-30 | 22.22M shares 10-Q · filed 2025-11-05 | 23.13M shares 10-Q · filed 2025-11-05 | ||||||
| 2024-06-30 | 23.59M shares 10-Q · filed 2025-08-06 | 23.24M shares 10-Q · filed 2025-08-06 | ||||||
| 2024-03-31 | 1.95M shares 10-Q · filed 2025-05-07 | |||||||
| 2023-12-31 | 1.92M shares 10-K · filed 2026-02-25 | |||||||
| 2023-09-30 | 1.98M shares 10-Q · filed 2024-11-06 | 1.88M shares 10-Q · filed 2024-11-06 | ||||||
| 2023-06-30 | 23.02M shares 10-Q · filed 2024-07-31 | 1.85M shares 10-Q · filed 2024-07-31 | ||||||
| 2023-03-31 | 1.92M shares 10-Q · filed 2024-05-08 | |||||||
| 2022-12-31 | 930.00K shares 10-K · filed 2025-02-26 | |||||||
| 2022-09-30 | 1.23M shares 10-Q · filed 2023-11-01 | 754.00K shares 10-Q · filed 2023-11-01 | ||||||
| 2022-06-30 | 642.00K shares 10-Q · filed 2023-08-02 | 514.00K shares 10-Q · filed 2023-08-02 | ||||||
| 2022-03-31 | 386.00K shares 10-Q · filed 2023-05-09 | |||||||
| 2021-12-31 | 979.00K shares 10-K/A · filed 2024-03-05 | |||||||
| 2021-09-30 | 891.00K shares 10-Q · filed 2022-11-09 | 1.05M shares 10-Q · filed 2022-11-09 | ||||||
| 2020-12-31 | 1.19M shares 10-K · filed 2023-02-28 | |||||||
| 2017-12-31 | 2.12M shares 10-K · filed 2018-02-23 | |||||||
| 2017-09-30 | 1.78M shares 10-Q · filed 2017-11-03 | 2.29M shares 10-Q · filed 2017-11-03 | ||||||
| 2017-06-30 | 2.02M shares 10-Q · filed 2017-08-08 | 2.54M shares 10-Q · filed 2017-08-08 | ||||||
| 2017-03-31 | 3.06M shares 10-Q · filed 2017-05-05 | |||||||
| 2016-12-31 | 4.07M shares 10-K · filed 2018-02-23 | |||||||
| 2016-09-30 | 3.88M shares 10-Q · filed 2017-11-03 | 16.85M shares 10-Q · filed 2017-11-03 | ||||||
| 2016-06-30 | 4.28M shares 10-Q · filed 2017-08-08 | 17.14M shares 10-Q · filed 2017-08-08 | ||||||
| 2016-03-31 | 17.33M shares 10-Q · filed 2017-05-05 | |||||||
| 2015-12-31 | 19.84M shares 10-K · filed 2018-02-23 | |||||||
| 2015-09-30 | 19.46M shares 10-Q · filed 2016-11-03 | 20.10M shares 10-Q · filed 2016-11-03 | ||||||
| 2015-06-30 | 19.86M shares 10-Q · filed 2016-08-04 | 20.19M shares 10-Q · filed 2016-08-04 | ||||||
| 2015-03-31 | 20.29M shares 10-Q · filed 2016-05-05 | |||||||
| 2014-12-31 | 20.34M shares 10-K · filed 2017-02-28 | |||||||
| 2014-09-30 | 20.65M shares 10-Q · filed 2015-11-05 | 20.10M shares 10-Q · filed 2015-11-05 | ||||||
| 2014-06-30 | 21.66M shares 10-Q · filed 2015-08-06 | 24.00M shares 10-Q · filed 2014-08-07 | 21.58M shares 10-Q · filed 2015-08-06 | 23.81M shares 10-Q · filed 2014-08-07 | ||||
| 2014-03-31 | 18.29M shares 10-Q · filed 2015-05-08 | 5.99M shares 10-Q · filed 2014-05-07 | ||||||
| 2013-12-31 | 9.24M shares 10-K · filed 2016-02-24 | 6.88M shares 10-K · filed 2014-03-03 | ||||||
| 2013-09-30 | 16.51M shares 10-Q · filed 2014-11-04 | 14.09M shares 10-Q · filed 2013-11-01 | 22.84M shares 10-Q · filed 2014-11-04 | 20.42M shares 10-Q · filed 2013-11-01 | ||||
| 2013-06-30 | 20.86M shares 10-Q · filed 2014-08-07 | 20.16M shares 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | 19.73M shares 10-Q · filed 2014-05-07 | |||||||
| 2012-12-31 | 14.54M shares 10-K · filed 2015-02-27 | 12.04M shares 10-K · filed 2013-02-26 | ||||||
| 2012-09-30 | 11.77M shares 10-Q · filed 2013-11-01 | 9.58M shares 10-Q · filed 2013-11-01 | 2.92M shares 10-Q · filed 2012-10-31 | |||||
| 2012-06-30 | 13.02M shares 10-Q · filed 2013-08-01 | 3.80M shares 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | 4.64M shares 10-Q · filed 2013-05-01 | |||||||
| 2011-12-31 | 12.13M shares 10-K · filed 2014-03-03 | |||||||
| 2011-09-30 | 13.41M shares 10-Q · filed 2012-10-31 | 12.87M shares 10-Q · filed 2012-10-31 | ||||||
| 2011-06-30 | 12.14M shares 10-Q · filed 2012-08-01 | 12.28M shares 10-Q · filed 2012-08-01 | ||||||
| 2011-03-31 | 13.34M shares 10-Q · filed 2012-05-02 | |||||||
| 2010-12-31 | 13.30M shares 10-K · filed 2013-02-26 | |||||||
| 2009-12-31 | 13.76M shares 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |